Hyaluronan/methylcellulose hydrogel with anti-inflammatory peptide and brain-derived neurotrophic factor (BDNF) |
Minimally swelling, sustained release; reduces inflammation, promotes neuronal survival |
Spinal cord injury |
[14] |
2,2,6,6-Tetramethylpiperidinyloxy (TEMPO)-functionalized hyaluronic acid hydrogel |
Antioxidant effect; promotes tissue reconnection, protects bladder tissue |
Spinal cord transection |
[15] |
Chitosan/hyaluronic acid hydrogel for nerve growth factor (NGF) sustained release |
Rapid gelation, interconnected channels, controllable pore diameter, suitable swelling and degradation behavior |
Peripheral nerve regeneration |
[41] |
Lithium-loaded hyaluronic acid hydrogel |
Neuroprotective, anti-inflammatory; promotes nerve regeneration |
Peripheral nerve injury |
[42] |
Matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel containing BDNF |
Promotes stem cell differentiation, contains IKVAV peptide and BDNF, supports neural differentiation |
Spinal cord injury |
[48] |
Hyaluronic acid/phenylboronic acid/poly (vinyl alcohol)/heparin hydrogel loaded with glial cell-derived neurotrophic factor (GDNF) |
Injectable, antioxidative, anti-inflammatory, biocompatible, sustained release; supports nerve regeneration |
Peripheral nerve injury |
[58] |
Hyaluronic acid granular hydrogel nerve guidance conduit |
Simulates extracellular matrix, promotes axonal extension. |
Peripheral nerve injury |
[59] |